David Schreck – Luvantas

Home
Our Story
Leadership
Careers
News
Contact

Home
Our Story
Leadership
Careers
News
Contact

Medytox, Inc. Announces the Formation of Luvantas Subsidiary and Appointment of Key Executives

IRVINE, Calif., Jan. 3, 2024 /PRNewswire/ — Medytox, Inc. is pleased to announce the formation of Luvantas, Inc. (www.luvantas.com) as its wholly-owned

Medytox submits BLA for non-animal-derived liquid BTX formulation in US

Medytox said it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for MT10109L, a non-animal-derived liquid botulinum toxin (BTX) formulation indicated for improving moderate to severe frown lines and crow’s feet.

© 2025 Luvantas® All rights reserved. All trademarks are the property of their respective owners.

Privacy Policy
Terms of Use
Site Design by Leftcoast Studios

Privacy Policy
Terms of Use
Site Design by Leftcoast Studios

Privacy Policy
Terms of Use
Site Design by Leftcoast Studios

Privacy Policy
Terms of Use
Site Design by Leftcoast Studios